Metabolic Contrasts: Fatty Acid Oxidation and Ketone Bodies in Healthy Brains vs. Glioblastoma Multiforme

• Published in: International journal of molecular sciences Vol. 25; no. 10; p. 5482
• Main Authors: Tamas, Corina, Tamas, Flaviu, Kovecsi, Attila, Cehan, Alina, Balasa, Adrian
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 17-05-2024
• Subjects: Adenosine triphosphate; Animals; B cells; Brain; Brain - metabolism; Brain - pathology; Brain cancer; Brain Neoplasms - metabolism; Brain Neoplasms - pathology; Brain tumors; Cancer therapies; carnitine; Catalysis; Cell death; Dehydrogenases; Dextrose; Energy; Enzymes; Fatty acids; Fatty Acids - metabolism; glioblastoma; Glioblastoma - metabolism; Glioblastoma - pathology; Glioblastoma multiforme; Glioma; Glucose; Glucose metabolism; Health aspects; Homeostasis; Humans; Hydration; ketone bodies; Ketone Bodies - metabolism; Kinases; Lipid Metabolism; Lipids; Medical prognosis; Metabolism; Mitochondria; Neurophysiology; Oxidation; Oxidation-Reduction; Oxidation-reduction reaction; Physiological aspects; Proteins; Tumor Microenvironment; Tumors; β-oxidation; β-oxidation; carnitine; ketone bodies; glioblastoma; fatty acids; lipid metabolism
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms25105482

The metabolism of glucose and lipids plays a crucial role in the normal homeostasis of the body. Although glucose is the main energy substrate, in its absence, lipid metabolism becomes the primary source of energy. The main means of fatty acid oxidation (FAO) takes place in the mitochondrial matrix through β-oxidation. Glioblastoma (GBM) is the most common form of primary malignant brain tumor (45.6%), with an incidence of 3.1 per 100,000. The metabolic changes found in GBM cells and in the surrounding microenvironment are associated with proliferation, migration, and resistance to treatment. Tumor cells show a remodeling of metabolism with the use of glycolysis at the expense of oxidative phosphorylation (OXPHOS), known as the Warburg effect. Specialized fatty acids (FAs) transporters such as FAT, FABP, or FATP from the tumor microenvironment are overexpressed in GBM and contribute to the absorption and storage of an increased amount of lipids that will provide sufficient energy used for tumor growth and invasion. This review provides an overview of the key enzymes, transporters, and main regulatory pathways of FAs and ketone bodies (KBs) in normal versus GBM cells, highlighting the need to develop new therapeutic strategies to improve treatment efficacy in patients with GBM.